=Epizyme (EPZM) reported earnings on Fri 4 Aug 2017 (b/o)

CAMBRIDGE, Mass. (AP) _ Epizyme Inc. (EPZM) on Friday reported a loss of $28 million in its second quarter.

On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 48 cents.

The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 56 cents per share.

The biopharmaceutical company posted revenue of $10 million in the period, also surpassing Street forecasts. Three analysts surveyed by Zacks expected $3.7 million.

Epizyme shares have climbed nearly 3 percent since the beginning of the year. The stock has climbed 23 percent in the last 12 months.